Invention Grant
- Patent Title: Peptidylarginine deiminase (PAD) inhibitors
- Patent Title (中): 肽基精氨酸脱亚氨酶（PAD）抑制剂
-
Application No.: US12965536Application Date: 2010-12-10
-
Publication No.: US08404647B2Publication Date: 2013-03-26
- Inventor: Richard Hendrik Blaauw , Gerardus Jozef Maria Pruijn , Jozef Maria Hendrik Raats , Floris Petrus Johannes Theodorus Rutjes , Jan Wouter Drijfhout
- Applicant: Richard Hendrik Blaauw , Gerardus Jozef Maria Pruijn , Jozef Maria Hendrik Raats , Floris Petrus Johannes Theodorus Rutjes , Jan Wouter Drijfhout
- Applicant Address: NL Nijmegen NL Nijmegen NL Leiden
- Assignee: Chiralix B.V.,Modiquest B.V.,Academisch Ziekenhuis Leiden H.O.D.N. Lumc
- Current Assignee: Chiralix B.V.,Modiquest B.V.,Academisch Ziekenhuis Leiden H.O.D.N. Lumc
- Current Assignee Address: NL Nijmegen NL Nijmegen NL Leiden
- Agency: Sunstein Kann Murphy & Timbers LLP
- Priority: EP08158330 20080616
- Main IPC: A61K38/10
- IPC: A61K38/10 ; A61K38/16 ; A61K38/08
Abstract:
The invention relates to PAD inhibitors that are suitable to be used as a medicament against an autoimmune disease such as RA.
Public/Granted literature
- US20110142868A1 Peptidylarginine Deiminase (PAD) Inhibitors Public/Granted day:2011-06-16
Information query
IPC分类:
